Clinical trial · Observational
Metabolic Differences Between Subtypes of Polycystic Ovary Syndrome
Serum Uric Acid Levels in Polycystic Ovary Syndrome Subtypes.
NCT06342180CI-TRIAL-00075640completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We aimed to investigate serum uric acid levels in patients with different phenotype of policystic ovary syndrome and to compare healthy controls.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Uric Acid Concentration, Serum, Quantitative Trait Locus 7 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Serum uric acid level | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- label
- Controls
- description
- Healthy controls between aged 18 and 35 years
- interventionNames
- Diagnostic Test: Serum uric acid level
- label
- PCOS Subtype 1
- description
- Hyperandrogenemia+oligoanovulation+PCO appearance on USG
- interventionNames
- Diagnostic Test: Serum uric acid level
- label
- PCOS Subtype 2
- description
- Hyperandrogenemia+oligoanovulation
- interventionNames
- Diagnostic Test: Serum uric acid level
- label
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients who applied for reasons such as hair growth, acne, menstrual irregularity or infertility and were diagnosed with PCOS after examination, biochemical, hormonal and sonographic tests, 2. Female patients between the ages of 18-35, 3. Patients without known cancer, liver or kidney failure, 4. Patients who do not take medications that will affect uric acid levels, 5. Female patients without active infection will be included. - Exclusion Criteria: 1. Female patients under eighteen years of age and \>35 years of age, 2. Patients with known cancer, liver and kidney failure, 3. Patients taking medications that will affect uric acid levels, 4. Patients with active infection will be excluded. -
References
Publications (1)
- DERIVEDAkkus C, Oner O, Okan Kilic A, Ucar Toros M, Duran C. Serum uric acid levels in patients with different phenotypes of polycystic ovary syndrome. Indian J Med Res. 2025 Dec;162(6):856-862. doi: 10.25259/IJMR_1903_2025. PMID 41648982